SCHEMBL26036680

SCHEMBL26036680

CC(=O)Oc1cccc2cc(C)ccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.50
LMNA P02545 2/20 0.50
CYP1A2 P05177 1/20 0.50
ALDH1A1 P00352 4/20 0.47
GAA P10253 2/20 0.47
POLB P06746 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 2/20 0.47
BLM P54132 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
MAPT P10636 1/20 0.47
APEX1 P27695 1/20 0.47
RECQL P46063 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAPK1 P28482 2/20 0.45
PTGS1 P23219 2/20 0.45
HSD17B10 Q99714 2/20 0.45
ACHE P22303 1/20 0.45
PGR P06401 1/20 0.45
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8399022 0.87 LMNA (0.50) MAOBLMNACYP1A2ALDH1A1GAA
SCHEMBL13588242 0.86 CYP1A2 (0.46) MAOBLMNACYP1A2ALDH1A1GAA
SCHEMBL9476254 0.83 KDM4E (0.50) LMNAALDH1A1GAAPOLBKMT2A
SCHEMBL9035473 0.81 HTT (0.57) MAOBLMNACYP1A2ALDH1A1GAA
SCHEMBL7099992 0.81 MTNR1A (0.52) CYP1A2ALDH1A1GAAPOLBKMT2A
SCHEMBL4328550 0.81 ALDH1A1 (0.58) LMNACYP1A2ALDH1A1GAAPOLB
Alpha-Naphthylacetate SCHEMBL29372782 0.80 ALDH1A1 (0.66) ALDH1A1GAAPOLBKMT2AKDM4E
Alpha-Naphthylacetate SCHEMBL76633 0.80 ALDH1A1 (0.66) ALDH1A1GAAPOLBKMT2AKDM4E
SCHEMBL10630235 0.80 ESR1 (0.53) CYP1A2ALDH1A1GAAPOLBKMT2A
SCHEMBL487105 0.80 ALDH1A1 (0.43) ALDH1A1GAAPOLBKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11739047-B2 Alpha-truxillic acid derivatives and pharmaceutical compositions thereof THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2023-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11739047-B2 Alpha-truxillic acid derivatives and pharmaceutical compositions thereof FABP1, FABP2, FABP4 MAOB 1888/4885LMNA 1187/4885CYP1A2 2127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.